Keeping you up to date with the latest clinical trial information
Multiple Sclerosis
Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach
Systemic sclerosis is an autoimmune disease characterized by immunological abnormalities,
vascular damage, and fibroblast proliferation. We have previously shown that a molecular
mimicry mechanism links antibodies against the human-cytomegalovirus-derived protein UL94
to the pathogenesis of systemic sclerosis.
Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
Despite the significant progress in increasing our understanding of the immune mechanisms of multiple sclerosis (MS), in improving clinical classification and brain imaging, and in developing new treatments, the factors that determine the course of the disease are mostly unknown.
Test Your Knowledge: Ten Questions about Multiple Sclerosis
Concerns about adverse events, including deaths, in recent large clinical trials, both publicly and privately sponsored,
prompted Elias A. Zerhouni, Director, National Institutes of Health (NIH) to convene a meeting at the NIH
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Growing awareness and accumulating data regarding the cognitive impairment and its progression in multiple sclerosis (MS) patients has received an important place in neurological research in the last decade.
Selected Reading
Auditory Function in Patients With and Without Multiple Sclerosis
We propose to evaluate auditory function and neuropsychologic function in 150 Multiple Sclerosis (MS) patients and in 150 patients who do not have MS. Experimental subjects will be recruited by selecting patients with a verified diagnosis of MS from the registry of patients established by the Oregon Health Sciences University, Multiple Sclerosis Research Center. Control subjects will be matched with respect to age, to gender and to audiometric configuration.
Selected Reading
Treatment for: Multiple Sclerosis
